Most Read News

Total revenue, including other revenue, rose to ₹6,066.52 crore in the March quarter, a 12% growth and the highest quarterly revenue in ACC's history.

Based on the Phase 2b clinical trial, the study used a randomised, double-blind, placebo-controlled design that yielded strong and dependable data.

The company's balance sheet expanded to ₹65,546 crore as of March 31, 2025, compared to ₹58,171 crore a year earlier.

Total income for the quarter ended March 2025 was at ₹63,748.80 lakh with sound operating performance.

The Board has proposed a final dividend of ₹45 per equity share of face value ₹1 each for the year ended March 31, 2025

The company announced a final dividend of ₹10 per equity share for FY25. The record date for the dividend is July 4, 2025.

As part of the transaction structure, Devyani International will acquire only three brands, while Krazy Kebab Co. and Get-A-Way will be disinvested within the next nine months.

Quarterly revenues of ₹40,674 crore trailed predicted ₹40,747 crore, yet arrived at a 6% sequential year-to-year better than last year's third-quarter ₹38,235 crore

The EBITDA for the quarter stood at ₹784.6 crore, much higher than the previous level.

HUL registered EBITDA of ₹3,466 crore in the March quarter, a 1% year-on-year increase. EBITDA margin for the quarter was 22.8%.